Oxycodon/Naloxon Develco (Oxycodone Hydrochloride, Naloxone Hydrochloride Dihydrate)

Oxycodone hydrochloride, the active ingredient in Oxycodon/Naloxon Develco, is an opioid analgesic presented as a combination tablet for oral use. It treats moderate to severe pain in adult patients when other analgesics are insufficient. GNH USA supplies Oxycodon/Naloxon Develco as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxycodon/Naloxon Develco is an opioid analgesic used in the management of pain pathways associated with severe acute and chronic pain conditions. - Cancer‑related pain: Provides strong analgesia to improve functional comfort. - Post‑operative pain: Controls pain after major surgical procedures. - Chronic non‑cancer pain: Offers long‑term relief when other treatments have failed. - Severe traumatic injury pain: Reduces intense pain from serious injuries. - Palliative care pain: Enhances quality of life for patients in end‑of‑life care.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Constipation: Reduced gastrointestinal motility. - Nausea: Sensation of queasy stomach. - Drowsiness: Generalized sedation. - Dry mouth: Decreased salivary flow. - Dizziness: Light‑headed feeling, especially on standing. - Sweating: Increased perspiration.

Serious or Rare Side Effects: - Respiratory depression: Marked reduction in breathing rate. - Severe hypotension: Dangerous drop in blood pressure. - Opioid dependence: Risk of physical and psychological addiction. - Hepatic dysfunction: Liver enzyme abnormalities. - Allergic reaction: Rash, itching, or anaphylaxis. - Seizures: Uncommon neurologic events.

When prescribing Oxycodon/Naloxon Develco, clinicians should consider several safety measures. - Assess pain severity: Confirm that opioid therapy is appropriate. - Review medical history: Identify respiratory, hepatic or renal impairment. - Monitor for dependence: Watch for signs of misuse or addiction. - Avoid abrupt discontinuation: Taper dose to prevent withdrawal. - Concomitant CNS depressants: Use with caution alongside benzodiazepines or alcohol. - Store below 25°C: Keep in the original packaging, protect from moisture and light.

Oxycodon/Naloxon Develco can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Benzodiazepines: Combined CNS depression increases risk of respiratory failure. - MAO inhibitors: May precipitate severe hypertension or serotonin syndrome. - CYP3A4 inhibitors (e.g., ketoconazole): Raise oxy‑cocaine [sic] plasma levels, heightening toxicity.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine): May reduce conversion of oxycodone to active metabolites. - Antihistamines: May enhance drowsiness and dizziness. - Diuretics: May exacerbate hypotension when combined with opioid‑induced vasodilation.